Billionaire Profile
Christian Boehringer
Global Rank
#669

Image: Public domain | via Wikimedia Commons

Christian Boehringer

CEO, Boehringer Ingelheim
DE
Real-Time Net Worth
$5.7B
As of December 2025
Age
60
Source
Pharmaceuticals
Industry
healthcare
Citizenship
DE

Biography

Christian Boehringer, a German billionaire, is a key figure in the world's largest privately-owned pharmaceutical company, Boehringer Ingelheim. Born in 1965, Boehringer, through family ownership, has played an active role in the company. His wealth stems from his stake in the company founded by his great-grandfather in 1885. With an estimated net worth of $5.7 billion, Boehringer has served as chairman of the shareholders' committee, guiding the research-driven enterprise that develops innovative medicines for both humans and animals. The family has maintained private ownership of the company for over a century, a rarity for a corporation of its global scale.

Wealth Over Time

In-Depth Profile

Early Life

Christian Boehringer was born in Wiesbaden, Germany, in 1965. He is a descendant of the Boehringer family, the founders of the pharmaceutical giant Boehringer Ingelheim. Christian grew up with his brother Mathias, and their family has a long-standing legacy in the pharmaceutical industry. His great-grandfather, Albert Boehringer, founded the company in 1885.

Rise to Success

Christian Boehringer's career path included roles in various sectors before returning to Boehringer Ingelheim. He worked as a Pharma-Product Manager in the UK and then transitioned to a European Pharma Consulting firm, which he led for three years. In 2000, he joined Henkel KGaA's international management team in Düsseldorf for three years. He then returned to Boehringer Ingelheim, where he took responsibility for global CRM project management, followed by a role as Area Manager for the USA, Canada, and Mexico.

Key Business Strategies

Boehringer Ingelheim has maintained a commitment to long-term, sustainable action. A key business strategy is its research and development investments, allocating a substantial portion of its revenue to innovation. In 2024, the company invested approximately €6.2 billion in R&D, equal to 23.2% of its group net sales. The company's focus on its employees is also a key factor, emphasizing innovation and mutual respect within the family-owned structure.

Philanthropy

Boehringer is involved in various initiatives promoting equal opportunities in education. Also, the company has maintained its corporate and social responsibility since its foundation in 1885.

Career Milestones

2007-2025

Chairman of the Shareholders' Committee

Overseeing the interests of the Boehringer Ingelheim's owner families. Serves as a steering body for the company's management.

2004-2007

Area Manager

Responsible for the USA, Canada, and Mexico.

2000-2003

Management

International management at Henkel KGaA in Düsseldorf.

1996-2000

Pharmaceutical Consultant

Self-employed in London.

Philanthropy & Social Impact

Education

Education Initiatives

Unknown

Boehringer Ingelheim and Christian Boehringer are involved in various initiatives promoting equal opportunities in education